Welcome to our dedicated page for Johnson Controls International SEC filings (Ticker: JCI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Johnson Controls International plc filings document an Irish public company with ordinary shares listed on the New York Stock Exchange and a capital structure that includes multiple series of senior notes and debentures, including sustainability-linked senior notes. Current reports on Form 8-K and amendments record material events and identify registered securities across equity and debt classes.
The company's proxy materials cover shareholder voting, board governance, executive compensation, sustainability governance and forward-looking risk disclosures. Form 25 records document exchange actions affecting listed debt securities, including removal from listing and registration of a note class.
Johnson Controls International plc reported new equity awards to an executive officer on December 1, 2025. EVP and Chief Human Resources Officer received 4,132 ordinary shares as restricted share units at a price of $0, increasing directly held ordinary shares to 27,779.47. The restricted share units, including accrued dividend equivalents, vest in three equal installments on December 7, 2026, December 7, 2027 and December 7, 2028 and convert to ordinary shares when vested.
The officer was also granted an employee stock option covering 15,796 derivative securities with a conversion or exercise price of $114.94 per ordinary share. Subject to certain acceleration and forfeiture provisions, fifty percent of these options become exercisable on December 7, 2027 and the remaining fifty percent on December 7, 2028, with the options expiring on December 1, 2035.
Johnson Controls International plc reported an equity award to one of its officers, the VP & President, Global Products. On 12/01/2025, the officer received 5,981 restricted share units, shown as ordinary shares acquired at a price of $0, bringing directly held ordinary shares to 72,761.5 after the transaction.
The filing also records an employee stock option grant covering 22,863 ordinary shares with an exercise price of $114.94 per share, dated 12/01/2025. Subject to acceleration and forfeiture provisions, fifty percent of the options become exercisable on December 7, 2027 and the remaining fifty percent on December 7, 2028, with an expiration date of 12/01/2035. The restricted share units vest in three equal installments on each of December 7, 2026, December 7, 2027 and December 7, 2028 and convert to ordinary shares upon vesting.
Johnson Controls International plc reported an equity award to its Chief Executive Officer on December 1, 2025. The CEO received 26,100 restricted share units, granted at a price of $0, increasing the CEO’s directly held ordinary shares to 58,253.18 after the transaction. These restricted share units are scheduled to vest in three equal installments on December 7, 2026, December 7, 2027 and December 7, 2028, and will convert into ordinary shares upon vesting while also accruing dividend equivalent units.
The CEO was also granted an employee stock option covering 99,767 ordinary shares at an exercise price of $114.94, with no upfront cost listed for the option itself. Subject to acceleration and forfeiture provisions, half of these options become exercisable on December 7, 2027 and the remaining half on December 7, 2028, and they expire on December 1, 2035.
Johnson Controls International plc reported a new equity award to its Executive Vice President & General Counsel. On 12/01/2025, the officer acquired 4,785 ordinary shares at a price of $0, described as restricted share units that, subject to acceleration and forfeiture provisions, vest in three equal installments on December 7, 2026, December 7, 2027 and December 7, 2028. Following this grant, the officer beneficially owns 33,662.391 ordinary shares directly.
The filing also shows a grant of an employee stock option covering 18,290 ordinary shares with an exercise price of $114.94 per share. Subject to certain conditions, half of these options become exercisable on December 7, 2027 and the remaining half on December 7, 2028, with an expiration date of December 1, 2035. The restricted share units accrue dividend equivalents and convert into ordinary shares upon vesting, providing long-term, performance-linked compensation.
Johnson Controls International plc reported a routine equity award to a senior executive. On December 1, 2025, the company granted 4,404 restricted share units, which are scheduled to vest in three equal installments on December 7, 2026, December 7, 2027, and December 7, 2028, and convert into ordinary shares upon vesting. The filing also discloses a grant of 16,835 employee stock options with an exercise price of $114.94 per share, half of which become exercisable on December 7, 2027 and the other half on December 7, 2028, with an expiration date of December 1, 2035. Following these grants, the reporting officer directly holds 63,314.55 ordinary shares and 16,835 stock options.
Johnson Controls International plc (JCI) executive VP & President, Global Products reported a sale of company stock in a Form 4 filing. On 11/21/2025, the reporting person sold 32,031 ordinary shares of JCI at a weighted average price of $113.20 per share, with individual trade prices ranging from $112.61 to $113.55. After this transaction, the insider beneficially owns 66,780.5 ordinary shares, held directly. The filing notes that detailed trade-by-trade pricing information within the reported range is available upon request from the issuer, any security holder, or the SEC staff.
Johnson Controls International (JCI) shareholder plans sale under Rule 144. A holder has filed notice to sell 32,031 shares of JCI common stock through Morgan Stanley Smith Barney LLC on or about 11/21/2025 on the NYSE, with an aggregate market value of 3,625,902.79. JCI had 611,135,655 common shares outstanding at the time referenced in the notice, providing context for the size of the planned sale. The shares to be sold were acquired primarily through restricted stock vesting under a registered plan in multiple transactions between 12/08/2023 and 11/14/2025, in exchange for services rendered. Over the past three months, the same seller disposed of 10,500 JCI shares for gross proceeds of 1,281,380.10.
Johnson Controls International plc (JCI) reported an insider transaction by a company officer on Form 4. The reporting person, an officer serving as VP, President Global Field Ops, filed as a single reporting person. On 11/18/2025, this officer disposed of 5,384 ordinary shares of JCI at a price of $114.44 per share. Following this transaction, the officer beneficially owned 58,910.55 ordinary shares, held in direct ownership. The filing shows no derivative security transactions, as the derivative securities table contains no entries.
Johnson Controls International plc (JCI) reported a change in insider holdings by a company officer. On 11/14/2025, the VP & President, Global Products reported a disposition of 16,408 ordinary shares at a price of $118.72 per share. After this transaction, the reporting person directly beneficially owns 98,811.5 ordinary shares of JCI. The filing is made on Form 4 by a single reporting person, reflecting their role as an officer of the company.
Johnson Controls International plc (JCI) reported an insider transaction by a director. On 11/13/2025, the director made a bona fide gift (Code G) of 4,890 ordinary shares at $0. After this transaction, the director beneficially owned 9,987.63 shares, held directly.